Cargando…
Reply to Mrakic-Sposta et al. Comment on “Menzel et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? Antioxidants 2021, 10, 414”
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230223/ https://www.ncbi.nlm.nih.gov/pubmed/34071260 http://dx.doi.org/10.3390/antiox10060865 |
| _version_ | 1783713157716377600 |
|---|---|
| author | Menzel, Alain Samouda, Hanen Dohet, Francois Loap, Suva Ellulu, Mohammed S. Bohn, Torsten |
| author_facet | Menzel, Alain Samouda, Hanen Dohet, Francois Loap, Suva Ellulu, Mohammed S. Bohn, Torsten |
| author_sort | Menzel, Alain |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8230223 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82302232021-06-26 Reply to Mrakic-Sposta et al. Comment on “Menzel et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? Antioxidants 2021, 10, 414” Menzel, Alain Samouda, Hanen Dohet, Francois Loap, Suva Ellulu, Mohammed S. Bohn, Torsten Antioxidants (Basel) Reply MDPI 2021-05-28 /pmc/articles/PMC8230223/ /pubmed/34071260 http://dx.doi.org/10.3390/antiox10060865 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Reply Menzel, Alain Samouda, Hanen Dohet, Francois Loap, Suva Ellulu, Mohammed S. Bohn, Torsten Reply to Mrakic-Sposta et al. Comment on “Menzel et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? Antioxidants 2021, 10, 414” |
| title | Reply to Mrakic-Sposta et al. Comment on “Menzel et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? Antioxidants 2021, 10, 414” |
| title_full | Reply to Mrakic-Sposta et al. Comment on “Menzel et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? Antioxidants 2021, 10, 414” |
| title_fullStr | Reply to Mrakic-Sposta et al. Comment on “Menzel et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? Antioxidants 2021, 10, 414” |
| title_full_unstemmed | Reply to Mrakic-Sposta et al. Comment on “Menzel et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? Antioxidants 2021, 10, 414” |
| title_short | Reply to Mrakic-Sposta et al. Comment on “Menzel et al. Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice—Which to Use Regarding Disease Outcomes? Antioxidants 2021, 10, 414” |
| title_sort | reply to mrakic-sposta et al. comment on “menzel et al. common and novel markers for measuring inflammation and oxidative stress ex vivo in research and clinical practice—which to use regarding disease outcomes? antioxidants 2021, 10, 414” |
| topic | Reply |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8230223/ https://www.ncbi.nlm.nih.gov/pubmed/34071260 http://dx.doi.org/10.3390/antiox10060865 |
| work_keys_str_mv | AT menzelalain replytomrakicspostaetalcommentonmenzeletalcommonandnovelmarkersformeasuringinflammationandoxidativestressexvivoinresearchandclinicalpracticewhichtouseregardingdiseaseoutcomesantioxidants202110414 AT samoudahanen replytomrakicspostaetalcommentonmenzeletalcommonandnovelmarkersformeasuringinflammationandoxidativestressexvivoinresearchandclinicalpracticewhichtouseregardingdiseaseoutcomesantioxidants202110414 AT dohetfrancois replytomrakicspostaetalcommentonmenzeletalcommonandnovelmarkersformeasuringinflammationandoxidativestressexvivoinresearchandclinicalpracticewhichtouseregardingdiseaseoutcomesantioxidants202110414 AT loapsuva replytomrakicspostaetalcommentonmenzeletalcommonandnovelmarkersformeasuringinflammationandoxidativestressexvivoinresearchandclinicalpracticewhichtouseregardingdiseaseoutcomesantioxidants202110414 AT ellulumohammeds replytomrakicspostaetalcommentonmenzeletalcommonandnovelmarkersformeasuringinflammationandoxidativestressexvivoinresearchandclinicalpracticewhichtouseregardingdiseaseoutcomesantioxidants202110414 AT bohntorsten replytomrakicspostaetalcommentonmenzeletalcommonandnovelmarkersformeasuringinflammationandoxidativestressexvivoinresearchandclinicalpracticewhichtouseregardingdiseaseoutcomesantioxidants202110414 |